Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Fibronectin Matrix Assembly after Spinal Cord Injury

Fibronectin Matrix Assembly after Spinal Cord Injury

JOURNAL OF NEUROTRAUMA, 2015 · DOI: 10.1089/neu.2014.3703 · Published: August 1, 2015

Spinal Cord InjuryGeneticsResearch Methodology & Design

Simple Explanation

After a spinal cord injury, scar tissue that contains glial and fibrotic components forms at the injury site. While the glial scar has received more attention, the fibrotic scar is made up of fibroblasts and a dense extracellular matrix (ECM). The fibrotic scar can inhibit axon growth, so understanding how it's formed may offer new insights into spinal cord injury pathology. Fibronectin, an extracellular matrix protein, is highly present in the fibrotic scar. After SCI, excess deposition of fibronectin comes from multiple sources, such as reactive astrocytes, macrophages, and fibroblasts. Fibronectin needs to polymerize into a fibrillar network to be a functional matrix, initiated by binding to cellular integrin receptors. However, whether or how this fibronectin matrix assembly occurs after SCI is not known. This study shows that fibronectin is assembled into a matrix to form the fibrotic scar, a process likely mediated by the fibronectin receptor integrin a5b1, which is primarily expressed by activated macrophages/microglia. The study also demonstrates the presence of fibrotic markers in a rat contusion model, highlighting the clinical relevance of the fibrotic scar.

Study Duration
Not specified
Participants
Mice and rats
Evidence Level
Not specified

Key Findings

  • 1
    Fibroblasts are the major source of fibronectin in the fibrotic scar after spinal cord injury. Deletion of fibronectin in myeloid cells did not change fibronectin expression level, indicating that fibroblasts are likely the major source.
  • 2
    Fibronectin is initially present in a soluble form after spinal cord injury, but assembles into a matrix at 7 days post-injury. This assembly is potentially mediated by the integrin a5b1 receptor, primarily expressed by activated macrophages/microglia in the fibrotic scar.
  • 3
    A fibrotic scar is observed in a rat spinal cord injury model, which is considered more similar to human pathology, indicating the clinical relevance of the fibrotic scar.

Research Summary

This study investigates the mechanism of fibrotic scar formation after spinal cord injury (SCI), focusing on fibronectin matrix assembly. The findings indicate that fibronectin starts forming a matrix around 7 days post-SCI, coinciding with fibroblast and macrophage/microglia infiltration. The research suggests that fibroblasts are the primary source of fibronectin in the fibrotic scar, while activated macrophages/microglia express the integrin a5b1 receptor, potentially playing a role in fibronectin matrix assembly. The presence of fibrotic scar markers in a rat SCI model highlights the clinical relevance of these findings, suggesting that fibrotic scarring after SCI may be present across species.

Practical Implications

Targeting Fibronectin Matrix

Understanding fibronectin matrix assembly after SCI may allow targeting of multiple inhibitory molecules in the fibrotic scar to promote axon regeneration.

Clinical Relevance

The presence of fibrotic scarring in rat SCI models suggests relevance to human SCI pathology, warranting further investigation.

Cell-Specific Therapies

Identifying fibroblasts as the primary source of fibronectin and macrophages/microglia expressing integrin a5b1 suggests cell-specific therapeutic targets.

Study Limitations

  • 1
    The study acknowledges the need for future research to delete fibronectin specifically in fibroblasts to confirm their role in fibrotic scar formation.
  • 2
    Genetic deletion of the a5b1 receptor specifically in macrophages/microglia is necessary to firmly conclude their role in fibronectin matrix assembly.
  • 3
    More functional studies are needed to fully support the proposed working model of fibronectin expression and regulation after SCI.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury